Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129140) titled 'AI-Assisted MRI Differentiation of Inflammatory Demyelinating Diseases' on July 31.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The first affiliated hostipal of nanchang university
Condition:
Inflammatory demyelinating diseases of the central nervous system, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Intervention:
Gold Standard:1. Upon signing by the principal investigator, this form is deemed to indicate the investigator's commitment that the resea...